Form 4: Agilon Health Executive Denise Zamore Reports Acquisition of Stock and Options
SEC Form 4 Filing
Chief Legal Officer Denise Zamore reports acquisition of common stock and options in Agilon Health, Inc.
Summary
- Denise Zamore, Chief Legal Officer of Agilon Health, Inc., filed a Form 4 on April 3, 2025, reporting transactions made on April 1, 2025.
- The report indicates the acquisition of 245,099 shares of common stock at $0, resulting in a total of 450,047 shares beneficially owned.
- Zamore also acquired 384,616 options with an exercise price of $4.08, exercisable from April 1, 2025, to April 1, 2035.
- These options vest in three equal installments on each anniversary of April 1, 2025, subject to continued employment.
- The reported transactions include restricted stock units vesting in three equal installments on each anniversary of April 1, 2025, subject to continued employment.
- The report also includes Performance Stock Units which may become vested subject to attainment (based on 40 trading day average closing price, exceeding twice the closing price of the Company's stock price on date of grant) and within three years from grant date.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard insider transaction report. The acquisition of shares and options by an executive is generally viewed as a positive sign, but it's not overwhelmingly positive.
Positives
- The acquisition of shares and options by a key executive could be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's view of the company's prospects.
Stakeholder Impact
- The reported transactions provide transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 04/01/2025 | Date of the reported transaction (acquisition of stock and options). |
| 04/01/2025 | Date from which restricted stock units vest in three equal installments annually, subject to continued employment. |
| 04/01/2025 | Date from which options vest in three equal installments annually, subject to continued employment. |
| 04/01/2035 | Expiration date of the acquired options. |
| 04/03/2025 | Date of Form 4 filing. |
Keywords
Form 4, insider trading, stock options, restricted stock units, common stock, Agilon Health, Zamore, acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.